Skip to main content
Log in

Combining endocrine and chemotherapy — any true benefits?

A panel discussion

  • Viewpoints
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Additional information

A series of teleconferences has been organized under the auspices of Mead Johnson to address several major current questions in oncology. A panel of recognized experts with a moderator has been assembled to discuss each question, and we will report a number of these discussions in this and succeeding issues of Breast Cancer Research and Treatment. This is reprinted from ‘Oncology Viewpoints’, courtesy of Mead Johnson Oncology Division, Evansville, IN 47721, USA.

Address for reprints: WL McGuire, M.D., Medicine/Oncology, University of Texas Health Science Center, San Antonio, TX 78284, USA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lippman, M.E., Buzdar, A., Tormey, D.C. et al. Combining endocrine and chemotherapy — any true benefits?. Breast Cancer Res Tr 4, 251–259 (1984). https://doi.org/10.1007/BF01806036

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806036

Keywords

Navigation